Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLEARVIEW WEALTH LIMITED Director's Dealing 2025

Nov 13, 2025

64733_rns_2025-11-13_4937be20-6fec-40d5-8c13-ebe4ae74ab1d.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity ClearView Wealth Limited
ABN 83 106 248 248

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Nadine Gooderick
Date of last notice 10 March 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving riseto the relevant interest. Jelwin Holdings Pty Ltd as thetrusteefortheJelwinSuperannuationFund.MsGooderick is a beneficiary ofthe fund and a director of thetrustee N/A
Date of change N/A 6 November 2025
No. of securities held prior to change 460,863 ORD Shares 2,609,044 Performance Rightsand 382,448 Restricted Rights91,226 Ordinary Shares
Class Ordinary Shares Performance RightsRestricted RightsOrdinary Shares
Number acquired Nil 1,610,813 Performance Rights(comprising 1,342,344Performance Rights and268,469 interim PerformanceRights),169,808 Restricted Rights63,756 Ordinary Shares(Appendix 3G lodged with ASXon 11 Sept 2025)
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed Nil Lapse of 277,777 FY22 LTVRPerformance Rights (Appendix3H lodged with ASX on 9 Sept2025)
Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation N/A N/A
No. of securities held after change 460,863 Ordinary Shares 3,942,080 Performance Rights488,500 Restricted Rights154,982 Ordinary Shares
Nature of changeExample: on-market trade, off-market trade, exerciseof options, issue of securities under dividendreinvestment plan, participation in buy-back N/A Grant of FY26 LTVR andiLTVR Performance Rights andFY25 STVR Restricted Rightspursuant to the ClearViewWealth Limited Rights Plan.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil
Nature of interest Nil
Name of registered holder(if issued securities) Nil
Date of change N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed Nil
Interest acquired Nil
Interest disposed Nil
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation Nil
Interest after change Nil

Part 3 –[+] Closed period

Were the interests in the securities or contracts No detailed above traded during a +closed period where prior written clearance was required? If so, was prior written clearance provided to Not applicable allow the trade to proceed during this period?

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If prior written clearance was provided, on what date was this provided?

Not applicable

  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3